Sensory-Motor Axonal NeuropathyEMGNCT07452081
Combined Effect of Sensory-motor Integration in Individuals With Postmenopausal Polyneuropathy
A study testing sensory motor integration and traditional excercises in people with Sensory-Motor Axonal Neuropathy, run by New Ismailia National University at 2 sites in 2 countries.
Trial summary
Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy Read more about this study
- Who is it for?
- Ages 45 to 55 years, women only
- Conditions the study is for
- Sensory-Motor Axonal Neuropathy
- What is being tested?
- sensory motor integration and traditional excercises
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 1 Feb 2026to 1 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 55 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- polyneuropathy pos-tmaneuposal
- Type II Diabetes Mellitus
- Suffering from numbness in upper and lower limbs for more than 4 months
Who cannot join
- hysterectomy
- tumors
- antidepressant dugs
Trial locations and contacts
2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.
2 sites in 2 countries
Egypt1 site, 1 recruiting
- Recruiting
Mohamed
Ismailia, 8332601
Mohamed AM Abo El Ros, Ph.D, 01206530584, mohamed.aboelros@pt.ninu.edu.eg
mohamed.aboelros@pt.ninu.edu.eg
Jordan1 site, 1 recruiting
- Recruiting
Zaytona University in Jordon
Amman
Mohamed M Abo-El-Ros, Ph.D, 00960781524278 ext. A, 3767@zuj.edu.jo
Kerolous I Kelini, Ph.D, 00201229712126 ext. S, 3530@zuj.edu.jo
About this study
Official title: The Combination Effect of Sensory-motor Integration in Postmenopausal Polyneuropathy: A Randomized Controlled Trial
Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy
Read the detailed description
This reach aim to conduct to improve balance and reduce pain in patients with post-menopausal with peripheral neuropathy
- Conditions
- Sensory-Motor Axonal Neuropathy
- Being tested
- sensory motor integration, traditional excercises
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
sensory motor integrationOther
Also called thermal, Tactile, and proprioceptive stimulation
pelvic rocking training and strengthening exercises
traditional excercisesOther
Also called Free exercises and gymnasium exercises of Upper limb and Lower limb
conventional
| Study group | Role | What they receive |
|---|---|---|
| Group A | Experimental | has received Sensory Motor Integration was given in the form of tactile stimulation, thermal stimulation and proprioceptive stimulation as well as motor integration was given in the form of strengthening exercises and pelvic rocking training for 6 weeks Receives: Other: sensory motor integration |
| Broup B | Active comparator | will recieve conventional exercises in the form of Free exercises and gymnasium exercises of Upper limb and Lower limb along with 20 minutes walking Receives: Other: traditional excercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
pain intensity
pain management will be evaluated by visual analogue scale with a minimum score of zero, and the maximum score is ten in addition, zero means a better score
Measured: 6 weeks
balance assessment
changes in balance parameters will be evaluated by the Biodex balance system that calculate the mediolateral stability index, anteroposterior stability index, and the overall. stability index.These indexes represent fluctuations around a zero point established before testing when the platform is stable. A high oSi score indicates poor balance, and the patient's maximum overall score would be 1.60.
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2026
- Study start1 Feb 2026
- Primary completion1 May 2026 (estimated)
- Study completion1 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sensory-Motor Axonal NeuropathyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- New Ismailia National University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abdel Moeim Abo EL Ros, Suez Canal University
- Investigators
- Kerlos Kellini, Ph.D, Study director, Al Zaytona University in Jordon
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07452081
- Sponsor's protocol ID
- IRB # 5/1/2025-2026
- Acronym
- EMG
- Status last verified
- Feb 2026
- First submitted
- 31 Jan 2026
- Last updated
- 5 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No IPD sharing
Study at a glance
From the registry record, last updated by the sponsor on 5 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Combination Effect of Sensory-motor Integration in Postmenopausal Polyneuropathy: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07452081
- Acronym / sponsor ID
- EMG / IRB # 5/1/2025-2026
- Conditions
- Sensory-Motor Axonal Neuropathy
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- New Ismailia National UniversityUniversity, hospital or other
- Study start
- 1 Feb 2026 (actual)
- Primary completion
- 1 May 2026 (estimated)
- Study completion
- 1 Jun 2026 (estimated)
- First posted
- 5 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy
Detailed description
This reach aim to conduct to improve balance and reduce pain in patients with post-menopausal with peripheral neuropathy
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy
| Arm | Type | Receives |
|---|---|---|
| Group A | Experimental | Other: sensory motor integrationhas received Sensory Motor Integration was given in the form of tactile stimulation, thermal stimulation and proprioceptive stimulation as well as motor integration was given in the form of strengthening exercises and pelvic rocking training for 6 weeks |
| Broup B | Active comparator | Other: traditional excerciseswill recieve conventional exercises in the form of Free exercises and gymnasium exercises of Upper limb and Lower limb along with 20 minutes walking |
Who may qualify
- Ages
- 45 to 55 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- polyneuropathy pos-tmaneuposal
- Type II Diabetes Mellitus
- Suffering from numbness in upper and lower limbs for more than 4 months
Key exclusion criteria (3 listed)
- hysterectomy
- tumors
- antidepressant dugs
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| sensory motor integrationAlso: thermal, Tactile, and proprioceptive stimulationpelvic rocking training and strengthening exercises | Other | Group A |
| traditional excercisesAlso: Free exercises and gymnasium exercises of Upper limb and Lower limbconventional | Other | Broup B |
Primary outcome
pain intensity
Time frame: 6 weeks
pain management will be evaluated by visual analogue scale with a minimum score of zero, and the maximum score is ten in addition, zero means a better score
balance assessment
Time frame: 6 weeks
changes in balance parameters will be evaluated by the Biodex balance system that calculate the mediolateral stability index, anteroposterior stability index, and the overall. stability index.These indexes represent fluctuations around a zero point established before testing when the platform is stable. A high oSi score indicates poor balance, and the patient's maximum overall score would be 1.60.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Mar 2026.
- Individual participant dataSharing planned: No. No IPD sharing
Related trials for Sensory-Motor Axonal Neuropathy
RecruitingObservational study
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
Charcot-Marie-Tooth, CMT1A
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingObservational study
Natural History Study for Charcot Marie Tooth Disease
Charcot-Marie-Tooth Disease, Charcot-Marie-Tooth
Active, not recruitingPhase 1/2
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)
RecruitingObservational study
Genotype/Phenotype Correlation of MORC2 Mutations
Charcot Marie Tooth Disease, DIFGAN
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kerlos Kellini, Ph.D study director
Al Zaytona University in Jordon
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing sensory motor integration and traditional excercises in people with Sensory-Motor Axonal Neuropathy, run by New Ismailia National University at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt, Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed AM Abo El Ros (01206530584, aboelroosmohamed61@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
pain intensity (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.